UK markets closed

Pulmonx Corporation (LUNG)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.45+1.73 (+22.41%)
As of 03:16PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-60,843
-60,843
-58,923
-48,661
-32,231
Depreciation & amortisation
1,548
1,548
1,513
867
483
Stock-based compensation
22,101
22,101
16,445
10,530
3,197
Change in working capital
-2,558
-2,558
-7,014
-7,846
-4,787
Accounts receivable
-3,104
-3,104
-2,190
-2,432
1,457
Inventory
918
918
-3,638
-6,458
-5,047
Accounts payable
-345
-345
247
87
592
Other working capital
-38,417
-38,417
-46,401
-45,059
-31,544
Other non-cash items
2,734
2,734
2,554
2,466
5,465
Net cash provided by operating activities
-37,610
-37,610
-45,083
-41,388
-30,633
Cash flows from investing activities
Investments in property, plant and equipment
-807
-807
-1,318
-3,671
-911
Purchases of investments
-46,200
-46,200
-47,187
-52,584
0
Sales/maturities of investments
45,000
45,000
44,280
10,000
13,605
Net cash used for investing activities
-2,007
-2,007
-4,225
-46,255
12,694
Cash flows from financing activities
Debt repayment
-94
-94
-87
0
-19,914
Common stock issued
-
-
-
0
201,392
Other financing activities
-
-
-53
-41
-4,499
Net cash used provided by (used for) financing activities
21,400
21,400
2,419
4,456
234,831
Net change in cash
-18,183
-18,183
-46,744
-83,081
217,025
Cash at beginning of period
101,967
101,967
148,711
231,792
14,767
Cash at end of period
83,784
83,784
101,967
148,711
231,792
Free cash flow
Operating cash flow
-37,610
-37,610
-45,083
-41,388
-30,633
Capital expenditure
-807
-807
-1,318
-3,671
-911
Free cash flow
-38,417
-38,417
-46,401
-45,059
-31,544